NYSE:PBYI

Puma Biotechnology Stock Predictions

Healthcare > Biotechnology

Buy PBYI

*Your capital is at risk

$6.81

-0.170 (-2.44%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

PBYI Prediction Chart

PBYI Predictions History

Latest community submissions for PBYI.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Aug 25, 2016	$56.80 -0.26%	$56.95	X	99.70%	4
kevin @kevin.439	Aug 25, 2016	$46.92 -17.61%	$56.95	X	82.40%	0
Stockdum Senior	Aug 8, 2016	$47.99 +4.24%	$46.04	X	95.80%	0
JS Pro	Aug 5, 2016	$45.56 -5.65%	$48.29	X	94.30%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PBYI with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PUMA BIOTECHNOLOGY INC

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by